HESTERBIO - Hester Biosciences Ltd Share Price

Pharmaceuticals & Biotechnology

Sharesguru Stock Score

HESTERBIO

39/100

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 4 years

₹2412.20-132.80(-5.22%)

Market Closed as of Jul 15, 2026, 15:29 IST

Select time range

Pros

Balance Sheet: Strong Balance Sheet.

Buy Backs: Company has bought back it's stock in the past which is a good thing.

Profitability: Very strong Profitability. One year profit margin are 17%.

Cons

Smart Money: Smart money is losing interest in the stock.

Valuation
Market Cap	1.8 kCr
Price/Earnings (Trailing)	31.39
Price/Sales (Trailing)	5.27
EV/EBITDA	20.04
Price/Free Cashflow	38.96
MarketCap/EBT	25.97
Enterprise Value	1.99 kCr

Fundamentals
Revenue (TTM)	342.28 Cr
Rev. Growth (Yr)	29.5%
Earnings (TTM)	57.48 Cr
Earnings Growth (Yr)	973.7%

Profitability
Operating Margin	19%
EBT Margin	20%
Return on Equity	15.63%
Return on Assets	8.48%
Free Cashflow Yield	2.57%

Growth & Returns
Price Change 1W	-3.5%
Price Change 1M	9.4%
Price Change 6M	35.9%
Price Change 1Y	18.2%
3Y Cumulative Return	7.2%
5Y Cumulative Return	-3.3%
7Y Cumulative Return	2.7%
10Y Cumulative Return	11.2%

Cash Flow & Liquidity
Cash Flow from Investing (TTM)	-3.29 Cr
Cash Flow from Operations (TTM)	64.14 Cr
Cash Flow from Financing (TTM)	-48.79 Cr
Cash & Equivalents	2.77 Cr
Free Cash Flow (TTM)	46.31 Cr
Free Cash Flow/Share (TTM)	54.44

Balance Sheet
Total Assets	677.94 Cr
Total Liabilities	310.15 Cr
Shareholder Equity	367.79 Cr
Current Assets	208.56 Cr
Current Liabilities	152.48 Cr
Net PPE	411.06 Cr
Inventory	72.53 Cr
Goodwill	0.00

Capital Structure & Leverage
Debt Ratio	0.28
Debt/Equity	0.51
Interest Coverage	5.35
Interest/Cashflow Ops	6.87

Dividend & Shareholder Returns
Dividend/Share (TTM)	11
Dividend Yield	0.52%
Shares Dilution (1Y)	0.00%
Shares Dilution (3Y)	0.00%

Technical Indicators
RSI (14d)	71.39
RSI (5d)	80.75
RSI (21d)	74.86
MACD Signal	Buy
Stochastic Oscillator Signal	Hold
SharesGuru Signal	Buy
RSI Signal	Sell
RSI5 Signal	Sell
RSI21 Signal	Sell
SMA 5 Signal	Buy
SMA 10 Signal	Buy
SMA 20 Signal	Buy
SMA 50 Signal	Buy
SMA 100 Signal	Buy

Description	Share	Value
Poultry Healthcare	64.6%	64.7 Cr
Animal Healthcare	35.4%	35.4 Cr
Total		100.1 Cr

Shareholder Name	Holding %
Rajiv Dinesh Gandhi	10.48%
Sanjiv Dinesh Gandhi	8.2%
Nina Rajiv Gandhi	8.19%
Shaila Bhupendra Gandhi	5.78%
Ravin Gandhi	4.74%
Bela Gandhi	4.71%
Bhupendra Vithaldas Gandhi	4.68%
Kuntal Hasmukhlal Shah	3.17%
Biolink Healthcare Limited	2.93%
Manish Jain	2.88%
Anup Chandravadan Kapadia	2.68%
Darshna Dinesh Kapadia	1.81%
Sandeep Shantilal Gala	1.3%
Vinay Shah	1.28%
Manish Jain (HUF)	1.23%
Jagrut Prataprai Gandhi	1.18%
Manish Prataprai Gandhi	1.18%
Investor Education and Protection Fund (IEPF)	1.02%
Hester Coatings LLP	0.75%
Hester Diagnostics Private Limited	0.28%

Ticker	Name	Mkt Cap	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
BAYERCROP	Bayer CropScience	19.83 kCr	5.71 kCr	-4.00%	-34.40%	27.69	3.18	-	-
AVANTIFEED	Avanti Feeds	12.87 kCr	6.28 kCr	-10.90%	+30.50%	20.75	2.05	-	-
SEQUENT	Sequent Scientific	12.42 kCr	2.68 kCr	+10.10%	+47.60%	87.49	4.64	-	-
GODREJAGRO	Godrej Agrovet	10.81 kCr	10.34 kCr	-0.90%	-27.60%	22.87	1.05	-	-

Description	(%) Q/Q	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Revenue From Operations	7.1%	333	311	305	266	235	214
Other Income	197.3%	9.68	3.92	11	15	14	4.68
Total Income	8.6%	342	315	315	281	249	219
Cost of Materials	11.1%	71	64	54	53	61	39
Purchases of stock-in-trade	-11.8%	16	18	33	30	13	7.97
Employee Expense	1.6%	63	62	64	56	45	39
Finance costs	-16.7%	11	13	20	9.32	4.06	6.6
Depreciation and Amortization	12.5%	19	17	17	21	17	13
Other expenses	2%	101	99	91	82	67	57
Total Expenses	-1.4%	276	280	288	246	196	166
Profit Before exceptional items and Tax	94.1%	67	35	27	36	53	53
Exceptional items before tax	-	2.94	0	0	0	0	-3.32
Total profit before tax	100%	69	35	27	36	53	50
Current tax	27.3%	15	12	11	11	15	17
Deferred tax	189.1%	3.21	-1.48	0.06	0.84	-0.77	-1.54
Total tax	70%	18	11	11	12	14	15
Total profit (loss) for period	100%	57	29	21	28	39	35
Other comp. income net of taxes	-254.3%	-2.33	0.06	-0.03	1.62	0.82	-1.58
Total Comprehensive Income	92.9%	55	29	21	30	40	33
Earnings Per Share, Basic	102.4%	67.57	33.89	24.88	32.96	46.41	40.79
Earnings Per Share, Diluted	102.4%	67.57	33.89	24.88	0	46.41	40.79

Description	(%) Q/Q	Mar-2026	Dec-2025	Sep-2025	Jun-2025	Mar-2025	Dec-2024
Revenue From Operations	30.3%	100	77	71	84	82	63
Other Income	-1121.2%	-3.03	0.67	9.73	2.32	-6.95	7.81
Total Income	24.7%	97	78	81	86	75	71
Cost of Materials	17.6%	21	18	17	14	16	17
Purchases of stock-in-trade	0%	5.65	5.65	-0.14	4.59	4.7	4.79
Employee Expense	0%	16	16	16	15	14	16
Finance costs	400%	5.1	1.82	2.21	1.81	5.62	-3.81
Depreciation and Amortization	43.1%	5.91	4.43	4.35	4.18	4.18	4.29
Other expenses	31.8%	30	23	24	24	28	22
Total Expenses	16.9%	77	66	66	67	73	59
Profit Before exceptional items and Tax	72.7%	20	12	15	19	2.44	12
Exceptional items before tax	-	2.94	0	0	0	0	0
Total profit before tax	100%	23	12	15	19	2.44	12
Current tax	295.3%	7.72	2.7	2.56	2.15	4.11	1.65
Deferred tax	-135.3%	0.82	1.51	0.14	0.74	-1.91	0.31
Total tax	134.9%	8.54	4.21	2.7	2.89	2.2	1.96
Total profit (loss) for period	92.5%	17	9.31	14	17	1.54	11
Other comp. income net of taxes	-15.6%	-0.63	-0.41	-1.12	-0.18	-0.17	-0.37
Total Comprehensive Income	89.9%	16	8.9	13	17	1.37	11
Earnings Per Share, Basic	85.6%	19.45	10.94	16.85	20.33	1.82	13.41
Earnings Per Share, Diluted	85.6%	19.45	10.94	16.85	20.33	1.82	13.41

Description	(%) Q/Q	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Revenue From Operations	2.1%	292	286	285	254	219	208
Other Income	76.6%	7.64	4.76	4.26	5.32	4.66	1.65
Total Income	3.1%	300	291	289	259	224	210
Cost of Materials	18.4%	46	39	33	29	35	24
Purchases of stock-in-trade	-13.6%	39	45	57	55	39	25
Employee Expense	-3.7%	53	55	57	48	39	33
Finance costs	41.2%	7.17	5.37	5.09	6.5	2.47	3.95
Depreciation and Amortization	18.7%	10	8.58	9.78	9.79	9.5	9.63
Other expenses	-2.3%	85	87	81	71	58	50
Total Expenses	-4.8%	237	249	253	215	171	150
Profit Before exceptional items and Tax	51.2%	63	42	37	44	53	60
Exceptional items before tax	-	7	0	0	0	0	-5.28
Total profit before tax	68.3%	70	42	37	44	53	55
Current tax	30%	14	11	9.63	11	14	16
Deferred tax	190.2%	3.12	-1.35	-0.06	0.86	-0.51	-1.48
Total tax	90.6%	18	9.92	9.57	12	14	15
Total profit (loss) for period	64.5%	52	32	27	32	40	40
Other comp. income net of taxes	22.8%	-0.05	-0.36	-0.02	0.11	-0.16	0.21
Total Comprehensive Income	70%	52	31	27	32	39	40
Earnings Per Share, Basic	65.4%	61.24	37.43	31.93	38.018	46.45	46.9
Earnings Per Share, Diluted	65.4%	61.24	37.43	31.93	38.018	46.45	46.9

Description	(%) Q/Q	Mar-2026	Dec-2025	Sep-2025	Jun-2025	Mar-2025	Dec-2024
Revenue From Operations	34.8%	94	70	65	63	77	63
Other Income	10500%	4.18	1.03	1.48	0.95	1.06	1.3
Total Income	38.6%	98	71	66	64	78	64
Cost of Materials	60%	17	11	9.71	8.68	9.02	8.44
Purchases of stock-in-trade	-26.4%	9.83	13	7.84	8.93	14	12
Employee Expense	8.3%	14	13	13	13	12	14
Finance costs	3190%	4.09	0.9	1.27	0.9	1.25	1.59
Depreciation and Amortization	121.5%	3.68	2.21	2.2	2.16	2.03	2.24
Other expenses	50%	28	19	19	18	25	19
Total Expenses	23.2%	70	57	56	54	66	58
Profit Before exceptional items and Tax	92.9%	28	15	9.88	10	11	6.49
Exceptional items before tax	-	7	0	0	0	0	0
Total profit before tax	142.9%	35	15	9.88	10	11	6.49
Current tax	373.2%	7.72	2.42	2.48	1.84	3.67	1.66
Deferred tax	-143.6%	0.76	1.55	0.19	0.61	-1.82	0.39
Total tax	152.2%	8.49	3.97	2.67	2.45	1.85	2.05
Total profit (loss) for period	150%	26	11	7.21	7.84	9.63	4.44
Other comp. income net of taxes	-28%	-0.05	0.18	-0.09	-0.09	-0.34	-0.01
Total Comprehensive Income	150%	26	11	7.12	7.75	9.29	4.43
Earnings Per Share, Basic	160.1%	31.01	12.54	8.48	9.21	11.33	5.22
Earnings Per Share, Diluted	160.1%	31.01	12.54	8.48	9.21	11.33	5.22

Description	(%) Q/Q	Mar-2026	Sep-2025	Mar-2025	Sep-2024	Mar-2024	Sep-2023
Cash and cash equivalents	-66.5%	2.77	6.29	5.59	14	13	13
Loans, current	-74.5%	0.11	0.49	5.76	5.79	5.86	5.83
Total current financial assets	1.7%	123	121	106	135	119	137
Inventories	10.8%	73	66	70	67	76	80
Total current assets	2.5%	209	204	195	222	215	238
Property, plant and equipment	71.5%	411	240	233	235	239	245
Capital work-in-progress	-	-	182	177	171	168	162
Non-current investments	-96.4%	2.3	37	0	0	0	0
Total non-current financial assets	-91%	4.59	41	5.58	3.52	3.79	5.06
Total non-current assets	-0.4%	469	471	458	447	448	445
Total assets	0.4%	678	675	653	669	662	683
Borrowings, non-current	-21.2%	90	114	133	155	182	190
Total non-current financial liabilities	-19.3%	97	120	140	164	190	197
Provisions, non-current	-18.3%	2.34	2.64	2.75	2.85	2.53	2.26
Total non-current liabilities	-13.7%	158	183	202	228	254	260
Borrowings, current	4.3%	98	94	74	84	57	77
Total current financial liabilities	3%	137	133	114	117	96	122
Provisions, current	10.4%	1.53	1.48	1.03	0.68	0.76	0.66
Current tax liabilities	3536.4%	5	1.11	4.02	2.43	2.46	2.69
Total current liabilities	7.9%	152	141	125	127	106	132
Total liabilities	-4.3%	310	324	327	355	359	391
Equity share capital	0%	8.51	8.51	8.51	8.51	8.51	8.51
Non controlling interest	-45.4%	7.55	13	12	12	11	9.61
Total equity	4.9%	368	351	327	314	303	292
Total equity and liabilities	0.4%	678	675	653	669	662	683

Description	(%) Q/Q	Mar-2026	Sep-2025	Mar-2025	Sep-2024	Mar-2024	Sep-2023
Cash and cash equivalents	72.7%	0.79	0.23	0.54	2.11	2.41	1.63
Loans, current	-2.3%	0.11	0.13	5.7	5.76	5.69	5.67
Total current financial assets	6.5%	116	109	108	129	115	131
Inventories	13.5%	60	53	59	61	69	73
Total current assets	6.2%	190	179	185	211	204	225
Property, plant and equipment	178.6%	288	104	105	107	103	104
Capital work-in-progress	-100.6%	0	182	177	171	168	162
Non-current investments	-1.6%	64	65	65	65	44	65
Total non-current financial assets	-1.5%	67	68	70	68	48	70
Total non-current assets	1.1%	368	364	361	351	345	339
Total assets	2.6%	557	543	546	562	550	564
Borrowings, non-current	-44.7%	22	39	51	64	79	88
Total non-current financial liabilities	-43.6%	23	40	52	65	80	88
Provisions, non-current	15.5%	2.34	2.16	2.38	2.52	2.26	1.98
Total non-current liabilities	-19.4%	80	99	110	125	139	145
Borrowings, current	-14.8%	53	62	53	74	54	74
Total current financial liabilities	-16.3%	78	93	90	108	94	114
Provisions, current	29.3%	1.53	1.41	0.92	0.57	0.67	0.63
Current tax liabilities	1136.1%	4.73	0.64	3.75	2.15	2	2.64
Total current liabilities	-4.2%	92	96	97	112	98	120
Total liabilities	-11.9%	172	195	207	237	237	265
Equity share capital	0%	8.51	8.51	8.51	8.51	8.51	8.51
Total equity	10.7%	385	348	339	325	313	299
Total equity and liabilities	2.6%	557	543	546	562	550	564

Description	(%) Q/Q	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Finance costs	-18.2%	10	12	19	8.99	0	-
Change in inventories	-208.3%	-3.55	5.2	9.23	-9.43	-13.16	-
Depreciation	12.5%	19	17	17	9.39	17	-
Unrealised forex losses/gains	665%	11	-0.77	-0.12	0.08	0.78	-
Adjustments for interest income	-44.2%	1.58	2.04	1.91	2.17	1.9	-
Net Cashflows from Operations	2.7%	78	76	60	32	26	-
Income taxes paid (refund)	30%	14	11	12	8.11	17	-
Net Cashflows From Operating Activities	-1.6%	64	65	48	24	8.81	-
Proceeds from sales of PPE	16.4%	0.39	0.27	0.06	0.03	0.18	-
Purchase of property, plant and equipment	-15%	18	21	24	78	96	-
Cash receipts from repayment of advances and loans made to other parties	-	5.5	0	0	0	0	-
Interest received	705.9%	2.03	0.83	1.89	0.51	0.26	-
Other inflows (outflows) of cash	-276.5%	-0.92	0.49	-0.21	0.23	-0.51	-
Net Cashflows From Investing Activities	78.6%	-3.29	-19	-22.65	-77	-116.59	-
Payments of other equity instruments	-	0	0	0	0	0.41	-
Proceeds from borrowings	-	0	0	20	56	135	-
Repayments of borrowings	9.4%	36	33	50	17	18	-
Payments of lease liabilities	-5.8%	0.27	0.31	0.3	0	0	-
Dividends paid	20.6%	6.03	5.17	6.8	8.51	8.51	-
Interest paid	-53%	6.64	13	15	13	2.54	-
Other inflows (outflows) of cash	-	0	0	26	24	6.19	-
Net Cashflows from Financing Activities	5.6%	-48.79	-51.72	-26.05	42	112	-
Effect of exchange rate on cash eq.	-951.7%	-14.88	-0.51	0.16	0.05	-0.35	-
Net change in cash and cash eq.	50.5%	-2.82	-6.72	-0.41	-11.59	3.48	-

Description	(%) Q/Q	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Finance costs	39.6%	6.71	5.09	4.89	6.26	0	-
Change in inventories	-127.4%	-1.47	10	11	-8.48	-13.72	-
Depreciation	18.7%	10	8.58	9.78	9.79	9.5	-
Unrealised forex losses/gains	-21.1%	-0.95	-0.61	-0.12	0.08	0.78	-
Adjustments for interest income	-44.2%	1.58	2.04	1.91	2.09	1.9	-
Net Cashflows from Operations	-13.7%	64	74	54	41	32	-
Income taxes paid (refund)	34.5%	13	9.92	11	8.06	16	-
Net Cashflows From Operating Activities	-20.6%	51	64	43	33	16	-
Proceeds from sales of PPE	16.4%	0.39	0.27	0.06	0.03	0.18	-
Purchase of property, plant and equipment	-20%	17	21	22	73	91	-
Cash receipts from repayment of advances and loans made to other parties	-	5.5	0	0	0	0	-
Interest received	705.9%	2.03	0.83	1.89	0.43	0.26	-
Other inflows (outflows) of cash	-276.5%	-0.92	0.49	-0.21	0.23	-20.36	-
Net Cashflows From Investing Activities	83.2%	-2.36	-19.04	-20.63	-71.96	-110.58	-
Proceeds from borrowings	-	0	0	20	52	118	-
Repayments of borrowings	21.4%	35	29	50	17	13	-
Payments of lease liabilities	-	0.06	0	0	0	0	-
Dividends paid	20.6%	6.03	5.17	6.8	8.51	8.51	-
Interest paid	-47.2%	7.33	13	13	9.87	1.36	-
Other inflows (outflows) of cash	-	0	0	26	24	0	-
Net Cashflows from Financing Activities	-4.1%	-48.31	-46.35	-24.07	41	95	-
Net change in cash and cash eq.	68.6%	0.24	-1.42	-1.89	2.77	0.28	-

HESTERBIO - Hester Biosciences Ltd Share Price

HESTERBIO

Price to Sales Ratio

Revenue (Last 12 mths)

Net Income (Last 12 mths)

HESTERBIO

HESTERBIO - Hester Biosciences Ltd Share Price

HESTERBIO

Valuation

Fundamentals

Profitability

Price to Sales Ratio

Revenue (Last 12 mths)

Net Income (Last 12 mths)

Growth & Returns

Cash Flow & Liquidity

Balance Sheet

Capital Structure & Leverage

Dividend & Shareholder Returns

HESTERBIO

Investor Care

Financial Health

Technical Indicators

Share Holdings

Holding Pattern

Share Holding Details

Overall Distribution

Ownership Distribution

What does Hester Biosciences Ltd do?

Important Disclosure & Data Context

Valuation

Fundamentals

Profitability

Growth & Returns

Cash Flow & Liquidity

Balance Sheet

Capital Structure & Leverage

Dividend & Shareholder Returns

Investor Care

Financial Health

Technical Indicators

Share Holdings

Holding Pattern

Share Holding Details

Overall Distribution

Ownership Distribution

What does Hester Biosciences Ltd do?

Important Disclosure & Data Context